Tue, 3 January 2017
Marijuana is undergoing a renaissance. It’s becoming more socially acceptable. Legal barriers to its use are being dismantled. And among some clinicians, its medicinal use is seen as a legitimate alternative to opioids and other therapies. But what do we really know about the health benefits or risks of cannabinoids, marijuana’s active ingredients?
In this QC Lunch & Learn Webinar recording, UNE pharmacology professor Christian Teter, Pharm.D., BCPP, explores the impact of cannabinoids on the developing brain and discovers that, as currently being used recreationally and medicinally, the harm they can do may outweigh the benefits. Join us to learn what we currently understand about cannabinoids – and what we don’t.
And for a legal perspective on marijuana use, sale and prescribing, the Maine Medical Association’s Gordon Smith will follow Christian’s presentation with a brief overview of current, and soon-to-be-implemented, Maine marijuana laws.